When we fed Quilty, a new AI tool that promises to analyze and provide insightful feedback on your scripts, the screenplays ...

Over the last two months, we have laid out in detail our ideas about the key issues in the birthright citizenship case, Trump ...

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding after CTEXLI's FDA approval. Japan Partner Sales -- $5 million recognized ...

Q4 2025 Earnings Call April 9, 2026 8:00 AM EDTCompany ParticipantsMeghan Roach - President, CEO & DirectorLeon Wu - ...

And as we sit now at the end of the first quarter, you will see that we significantly expanded our activities in equities ...

On this "Face the Nation with Margaret Brennan" broadcast, NASA Administrator Jared Isaacman and retired Gen. Frank McKenzie ...

Inscriptions found include notes on exercises by schoolchildren, religious texts, and certificates for the quality of ...

AI meeting tools that identify speakers may trigger BIPA compliance. Here’s how Illinois law, case law and AI regulation are shaping biometric risk for employers.

The Goldman Sachs Group, Inc. (NYSE:GS) Q1 2026 Earnings Call Transcript April 13, 2026 The Goldman Sachs Group, Inc. beats ...

Although the tenuous leadership of the DOJ under AG Pam Bondi is over, the department is still in upheaval because of so many ...

Stephen Sheldon, CFA, CPA, is a Partner with William Blair & Co., which he joined in September 2011. Mr. Sheldon is a technology Research Analyst focused on the real estate, education, and ...

Management expects completion of VISTAS study enrollment for Volixibat in PSC in the third quarter of 2025, with data readout expected in the second quarter of 2026. Recently approved CTEXLI is ...